C Vivek Lal MD, FAAP

Founder, Biostack Ventures

Dr. C. Vivek Lal, M.D., is a double board-certified physician, NIH-funded scientist, innovator, and serial entrepreneur.

In his academic role, Dr. Lal served as the Executive in Residence, Tenured Professor and as the Director of Pulmonary Microbiome & Discover Labs at the University of Alabama at Birmingham (UAB). As a double board certified neonatal intensivist physician, he served as the Director of Small Baby Program at UAB, one of the largest neonatal ICU’s in the country.

As a part of Biostack Ventures, Dr. Lal serves as the Founder and CEO of ResBiotic Nutrition, Inc., a company that makes science backed wellness supplements. He is also the Founder of Alveolus Bio, Inc., a platform biotech company which does FDA approved pulmonary drug development & co-founder of Urgent Care for Children, a Southeast US based urgent care chain headquartered in AL. In addition, Dr. Lal is the founder of Able Biolabs, a contract research organization for drug and nutraceutical development.

After medical school and residency training, Dr. Lal completed his clinical fellowship and research fellowship at University of Texas at Southwestern, Dallas, TX, followed by an executive program in Drug and Device Development from Massachusetts Institute of Technology (MIT). Dr. Lal’s Microbiome Lab has been funded by NIH-NHLBI and AHA to evaluate the role of the microbiome in the development of diseases. Dr. Lal has published over 100 peer reviewed research manuscripts or abstracts and has several patents under his name as an inventor. He has won several national and international awards in the field of human biology research.

“With Dr. Lal’s expertise as an astute businessman with a solid foundation – that of a world class physician-scientist-innovator, Biostack Ventures is positioned to become a national leader in the health innovation industry”

Business Advisor